Survival after relapse in patients with endometrial cancer: Results from a randomized trial

Gynecologic Oncology

Volumn 89, Issue 2, 2003, Pages 201-209

  Creutzberg, Carien L ^a,i   Van Putten, Wim L J ^a   Koper, Peter C ^a   Lybeert, Marnix L M ^b   Jobsen, Jan J ^c   Wárlám Rodenhuis, Carla C ^d   De Winter, Karin A J ^e   Lutgens, Ludy C H W ^f   Van Den Bergh, Alfons C M ^g   Van Der Steen Banasik, Elzbieta ^h   Beerman, Henk ^a   Van Lent, Mat ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b CATHARINA HOSPITAL   (Netherlands)

^c MEDISCH SPECTRUM TWENTE   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e DR BERNARD VERBEETEN INSTITUTE   (Netherlands)

^f MAASTRO CLINIC   (Netherlands)

^g UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^h Radiotherapy Institute Arnhem   (Netherlands)

ⁱ LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Endometrial carcinoma; Radiotherapy; Randomized trial; Salvage treatment; Vaginal recurrence

Indexed keywords

ABDOMINAL HYSTERECTOMY; ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER CONTROL; CANCER LOCALIZATION; CANCER PATIENT; CANCER RECURRENCE; CANCER REGRESSION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; FOLLOW UP; HUMAN; INVASIVE CARCINOMA; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; METASTASIS; MULTICENTER STUDY; MYOMETRIUM; PELVIS CANCER; POSTOPERATIVE CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; VAGINA CARCINOMA;

EID: 0344626922     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-8258(03)00126-4     Document Type: Article

References (30)

1. Poulsen M.G., Roberts S.J. The salvage of recurrent endometrial carcinoma in the vagina and pelvis. Int J Radiat Oncol Biol Phys. 15:1988;809-813.
2. Hoekstra C.J., Koper P.C., van Putten W.L. Recurrent endometrial adenocarcinoma after surgery alone prognostic factors and treatment . Radiother Oncol. 27:1993;164-166.
3. Sears J.D., Greven K.M., Hoen H.M., Randall M.E. Prognostic factors and treatment outcome for patients with locally recurrent endometrial cancer. Cancer. 74:1994;1303-1308.
4. Pai H.H., Souhami L., Clark B.G., Roman T. Isolated vaginal recurrences in endometrial carcinoma treatment results using high-dose-rate intracavitary brachytherapy and external beam radiotherapy . Gynecol Oncol. 66:1997;300-307.
5. Hart K.B., Han I., Shamsa F., Court W.S., Chuba P., Deppe G., Malone J., Christensen C., Porter A.T. Radiation therapy for endometrial cancer in patients treated for postoperative recurrence. Int J Radiat Oncol Biol Phys. 41:1998;7-11.
6. Curran W.J. Jr, Whittington R., Peters A.J., Fanning J. Vaginal recurrences of endometrial carcinoma the prognostic value of staging by a primary vaginal carcinoma system . Int J Radiat Oncol Biol Phys. 15:1988;803-808.
7. Mandell L.R., Nori D., Hilaris B. Recurrent stage I endometrial carcinoma results of treatment and prognostic factors . Int J Radiat Oncol Biol Phys. 11:1985;1103-1109.
8. Jereczek-Fossa B., Badzio A., Jassem J. Recurrent endometrial cancer after surgery alone results of salvage radiotherapy . Int J Radiat Oncol Biol Phys. 48:2000;405-413.
9. Ackerman I., Malone S., Thomas G., Franssen E., Balogh J., Dembo A. Endometrial carcinoma - relative effectiveness of adjuvant irradiation vs therapy reserved for relapse. Gynecol Oncol. 60:1996;177-183.
10. Wylie J., Irwin C., Pintilie M., Levin W., Manchul L., Milosevic M., Fyles A. Results of radical radiotherapy for recurrent endometrial cancer. Gynecol Oncol. 77:2000;66-72.
11. Burke T.W., Heller P.B., Woodward J.E., Davidson S.A., Hoskins W.J., Park R.C. Treatment failure in endometrial carcinoma. Obstet Gynecol. 75:1990;96-101.
12. Creutzberg C.L., van Putten W.L., Koper P.C., Lybeert M.L., Jobsen J.J., Warlam-Rodenhuis C.C., De Winter K.A., Lutgens L.C., van den Bergh A.C., Steen-Banasik E., Beerman H., van Lent M. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma multicentre randomised trial. PORTEC Study Group . Lancet. 355:2000;1404-1411.
13. Visser O., Coebergh J.W., Schouten L.J., Van Dijck J.A. Incidence of Cancer in the Netherlands 1995. 1998;43 Netherlands Cancer Registry, Utrecht.
14. Overledenen naar doodsoorzaak 1993. Statistics Netherlands/Centraal Bureau voor de Statistiek, 1998.
15. Reddoch J.M., Burke T.W., Morris M., Tornos C., Levenback C., Gershenson D.M. Surveillance for recurrent endometrial carcinoma development of a follow-up scheme . Gynecol Oncol. 59:1995;221-225.
16. Bond W.H. Early uterine body carcinoma has post-operative vaginal irradiation any value? Clin Radiol. 36:1985;619-623.
17. Podczaski E., Kaminski P., Gurski K., MacNeill C., Stryker J.A., Singapuri K., Hackett T.E., Sorosky J., Zaino R. Detection and patterns of treatment failure in 300 consecutive cases of "early" endometrial cancer after primary surgery. Gynecol Oncol. 47:1992;323-327.
18. Poulsen M.G., Roberts S.J. Prognostic variables in endometrial carcinoma. Int J Radiat Oncol Biol Phys. 13:1987;1043-1052.
19. Corn B.W., Lanciano R.M., D'agostino R., Kiggundu E., Dunton C.J., Purser P., Greven K.M. The relationship of local and distant failure from endometrial cancer defining a clinical paradigm . Gynecol Oncol. 66:1997;411-416.
20. Burke T.W. How should we monitor women treated for endometrial carcinoma? Gynecol Oncol. 65:1997;377-378.
21. Berchuck A., Anspach C., Evans A.C., Soper J.T., Rodriguez G.C., Dodge R., Robboy S., Clarke-Pearson D.L. Postsurgical surveillance of patients with FIGO stage I/II endometrial adenocarcinoma. Gynecol Oncol. 59:1995;20-24.
22. Shumsky A.G., Brasher P.M., Stuart G.C., Nation J.G. Risk-specific follow-up for endometrial carcinoma patients. Gynecol Oncol. 65:1997;379-382.
23. Re A., Taylor T.H., DiSaia P.J., Anton-Culver H. Risk for breast and colorectal cancers subsequent to cancer of the endometrium in a population-based case series. Gynecol Oncol. 66:1997;255-257.
24. Roberts J.A., Brunetto V.L., Keys H.M. A phase III randomized study of surgery vs. surgery plus adjunctive radiation therapy in intermediate risk endometrial adenocarcinoma (GOG#99). Gynecol Oncol. 68:1998;135. (Abstract).
25. Creutzberg C.L., van Putten W.L., Koper P.C., Lybeert M.L., Jobsen J.J., Warlam-Rodenhuis C.C., De Winter K.A., Lutgens L.C., van den Bergh A.C., Steen-Banasik E., Beerman H., van Lent M. The morbidity of treatment for patients with Stage I endometrial cancer results from a randomized trial . Int J Radiat Oncol Biol Phys. 51:2001;1246-1255.
26. Jereczek-Fossa B.A. Postoperative irradiation in endometrial cancer still a matter of controversy . Cancer Treat Rev. 27:2001;19-33.
27. Chadha M., Nanavati P.J., Liu P., Fanning J., Jacobs A. Patterns of failure in endometrial carcinoma stage IB grade 3 and IC patients treated with postoperative vaginal vault brachytherapy. Gynecol Oncol. 75:1999;103-107.
28. Weiss E., Hirnle P., Arnold-Bofinger H., Hess C.F., Bamberg M. Adjuvant vaginal high-dose-rate afterloading alone in endometrial carcinoma patterns of relapse and side effects following low-dose therapy . Gynecol Oncol. 71:1998;72-76.
29. Anderson J.M., Stea B., Hallum A.V., Rogoff E., Childers J. High-dose-rate postoperative vaginal cuff irradiation alone for stage IB and IC endometrial cancer. Int J Radiat Oncol Biol Phys. 46:2000;417-425.
30. Pearcey R.G., Petereit D.G. Post-operative high dose rate brachytherapy in patients with low to intermediate risk endometrial cancer. Radiother Oncol. 56:2000;17-22.